Skip to main content

Cardinal Health vs Intel: Founders, CEOs and History

Cardinal Health was founded in 1971 by Robert D. Walter and is led by Jason M. Hollar. Intel was founded in 1968 by Robert Noyce, Gordon Moore and is led by Lip-Bu Tan.

Company facts

Cardinal Health

Founded
1971
Headquarters
Dublin, Ohio, United States
Current CEO
Jason M. Hollar
Employees
63,900

Intel

Founded
1968
Headquarters
Santa Clara, California
Current CEO
Lip-Bu Tan
Employees
85,100

Founders

Cardinal Health

  • Robert D. Walter

    Cardinal Health possesses a unique and unexpected founding history: the pharmaceutical distributor was not founded by a doctor or a pharmacist, but rather by an ambitious entrepreneur attempting to consolidate the wholesale food industry.

Cardinal Health founders in full

Intel

  • Robert Noyce

    Intel possesses the most well-known founding story in the entire history of Silicon Valley, famously founded by the effective, rebellious engineers who essentially invented the fundamental architecture of the modern digital world.

  • Gordon Moore

    Gordon Moore co-founded Intel and served as a key technical leader, CEO, and chairman during the company's formative decades. His most important contribution was turning transistor scaling into a corporate operating philosophy.

Intel founders in full

CEOs and their tenures

Cardinal Health

  1. Robert D. Walter1971–2006

    Founder, Chairman, and CEO

    Walter founded Cardinal Health in 1971 as a food wholesaler and pivoted to pharmaceutical distribution in 1979. He executed dozens of acquisitions that transformed the company from a small regional distributor into a $50+ billion healthcare conglomerate.

    Source
  2. Kerry Clark2006–2009

    Chairman and CEO

    Clark led Cardinal Health through a period of strategic repositioning, including the spin-off of the CareFusion medical technology business. He focused on improving operational efficiency and addressing the challenges of the post-Walter era.

    Source
  3. George Barrett2009–2017

    Chairman and CEO

    Barrett led Cardinal Health through significant strategic initiatives including the acquisition of the Patient Recovery business from Medtronic ($6.1 billion) and the establishment of the Red Oak Sourcing joint venture with CVS Health.

    Source
  4. Mike Kaufmann2018–2022

    CEO

    Kaufmann led Cardinal Health through the opioid litigation settlement and the COVID-19 pandemic, which created demand for medical supplies and pharmaceuticals. He focused on operational execution and maintaining supply chain continuity during the crisis.

    Source
  5. Jason M. Hollar2022–present

    CEO

    Hollar joined Cardinal Health as CFO in 2020 and became CEO in September 2022. He has led the company through the OptumRx contract exit, the GMPD improvement plan, and acquisitions including GI Alliance, ADSG, and Solaris Health.

    Source
Cardinal Health CEO history in full

Intel

  1. Andy Grove1987–1998

    CEO

    Grove turned Intel into the dominant PC processor supplier; revenue grew from about $1.9B in 1987 to over $26B in 1998. His book 'Only the Paranoid Survive' became a management classic.

    Source
  2. Pat Gelsinger2021–2024

    CEO

    Gelsinger rebuilt Intel's process roadmap toward 18A, but capital spending outpaced revenue. After a $18.8B net loss in 2024 and a dividend suspension, the board pushed him out in December 2024.

    Source
  3. Lip-Bu Tan2025–present

    Chief Executive Officer

    Tan reframed Intel around customer commitments and cost discipline rather than building capacity ahead of demand. By Q2 2026 Intel had beaten guidance for several straight quarters and posted its fastest revenue growth in more than 15 years.

    Source
Intel CEO history in full

Timeline: Cardinal Health and Intel side by side

  1. 1968Intel

    Intel Founded

    Robert Noyce and Gordon Moore founded Intel.

  2. 1971Cardinal Health

    Cardinal Foods Founded by Robert D. Walter

    Robert D. Walter, a 26-year-old Harvard MBA graduate, borrowed $1.3 million to acquire the food-distribution division of Consolidated Foods in a leveraged buyout, establishing Cardinal Foods in Columbus, Ohio.

  3. 1971Intel

    4004 Microprocessor

    Intel introduced the 4004, one of the first commercial microprocessors.

  4. 1979Cardinal Health

    Pivot to Pharmaceutical Distribution

    Walter acquired Bailey Drug Co., a pharmaceutical distributor in Zanesville, Ohio, marking Cardinal's entry into pharmaceutical distribution.

  5. 1983Cardinal Health

    Cardinal Distribution Goes Public

    Cardinal Distribution Inc. completed its initial public offering on the NASDAQ at $1.03 per share, providing capital for continued expansion through acquisitions.

  6. 1984Cardinal Health

    Acquisition of Ellicott Drug

    Cardinal acquired Ellicott Drug, a pharmaceutical distributor in Buffalo, New York, continuing the acquisition-driven expansion strategy that would define the company's growth for decades.

  7. 1985Intel

    386 Processor

    Intel strengthened the x86 franchise that later dominated PCs.

  8. 1988Cardinal Health

    Sale of Food Operations to Roundy's Inc.

    Cardinal sold its remaining food operations to Roundy's Inc., completing the company's transition from a diversified food and drug distributor to a pure-play pharmaceutical distribution company.

  9. 1993Intel

    Pentium Processor Launched

    Intel introduced the Pentium processor in 1993.

  10. 1994Cardinal Health

    Name Change to Cardinal Health

    The company changed its name from Cardinal Distribution to Cardinal Health, reflecting its expanding mission beyond pure distribution into healthcare services, manufacturing, and technology. Revenues exceeded $1 billion by 1991.

  11. 1995Cardinal Health

    Acquisition of Medicine Shoppe International

    Cardinal acquired Medicine Shoppe International, the country's largest franchise of retail pharmacies, marking the company's first significant non-distribution acquisition and entry into retail pharmacy.

  12. 1996Cardinal Health

    Acquisition of Pyxis Corp.

    Cardinal acquired Pyxis Corp., a manufacturer of automated supply and pharmaceutical dispensing systems for hospitals, adding medical technology capabilities to the company's portfolio.

  13. 1999Cardinal Health

    Acquisition of Allegiance Healthcare Corp.

    Cardinal acquired Allegiance Healthcare Corp. for approximately $4.4 billion, becoming a major player in the medical-surgical products market and establishing the foundation for what would become the Global Medical Products and Distribution segment.

  14. 2006Intel

    Core Architecture

    Intel revived product leadership with the Core architecture.

  15. 2013Cardinal Health

    Red Oak Sourcing Joint Venture with CVS

    Cardinal Health and CVS Caremark announced the creation of Red Oak Sourcing, a 50/50 joint venture to form the largest generic pharmaceutical sourcing entity in the United States. The venture began operations in July 2014 with an initial 10-year term.

  16. 2014Cardinal Health

    Loss of Walgreens Contract

    Cardinal Health lost a major pharmaceutical distribution contract with Walgreens, which shifted its distribution to AmerisourceBergen. The contract had generated $3.3 billion in quarterly revenue.

  17. 2017Cardinal Health

    Acquisition of Patient Recovery Business from Medtronic

    Cardinal Health acquired the Patient Recovery business from Medtronic for $6.1 billion, expanding its medical products portfolio and adding significant scale to the Global Medical Products and Distribution segment.

  18. 2021Intel

    IDM 2.0 Announced

    Intel announced a strategy to expand manufacturing and foundry capabilities.

  19. 2021Intel

    Pat Gelsinger Becomes CEO

    Pat Gelsinger became Intel chief executive in February 2021.

  20. 2024Cardinal Health

    OptumRx Contract Non-Renewal Announced

    Cardinal Health's pharmaceutical distribution contracts with OptumRx (part of UnitedHealth Group) expired at the end of June 2024 and were not renewed. They represented about $38.1 billion of fiscal 2024 revenue.

  21. 2025Cardinal Health

    Fiscal 2025 Results and Raised FY2026 Guidance

    Cardinal Health reported fiscal 2025 revenue of $222.6 billion, down about 2% after the OptumRx contract expiration, while net earnings rose to about $1.6 billion.

  22. 2025Intel

    Lip-Bu Tan Becomes CEO

    Lip-Bu Tan became CEO and reset the turnaround agenda around execution, cost, and focus.

  23. 2025Intel

    $52.853B Revenue

    Intel reported $52.853B in revenue and a $267M net loss attributable to Intel.

  24. 2025Intel

    U.S. Government Takes 9.9% Stake

    The U.S. government bought 433.3 million Intel shares at $20.47 for $8.9 billion, becoming the largest shareholder.

  25. 2025Intel

    Nvidia Invests $5 Billion

    Nvidia agreed to invest $5 billion in Intel and co-develop x86 PC and data-center products.

  26. 2025Intel

    Altera Majority Sold

    Intel closed the sale of 51% of Altera to Silver Lake on September 12, 2025.

  27. 2026Cardinal Health

    Fiscal 2026 Revenue Reaches $254.2 Billion

    Fiscal 2026 revenue rose 14% to $254.2 billion and non-GAAP EPS rose 37% to $11.26, with profit growth in all five operating segments.

  28. 2026Intel

    Q2 Revenue Up 25%

    Intel reported $16.1 billion in Q2 2026 revenue, its fastest growth in more than 15 years.

Acquisitions

Cardinal Health

  • Advanced Diabetes Supply Group (ADSG)2025$1.1B
  • Solaris Health (via The Specialty Alliance)2025$1.9B
  • Integrated Oncology Network (ION)2024Undisclosed
  • GI Alliance (71% stake)2024$2.8B
  • Patient Recovery Business from Medtronic2017$6.1B
  • Allegiance Healthcare Corp.1999Undisclosed
All Cardinal Health acquisitions

Intel

  • Moovit2020$900M
  • Habana Labs2019$2B
  • Mobileye2017$15.3B
  • Altera2015$16.7B
  • McAfee2011$7.7B
All Intel acquisitions

Questions about Cardinal Health vs Intel

Who is the CEO of Cardinal Health, Inc. and Intel Corporation?

Cardinal Health, Inc. is led by Jason M. Hollar and Intel Corporation is led by Lip-Bu Tan. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Cardinal Health, Inc. founded vs Intel Corporation?

Intel Corporation was founded in 1968 — 3 years before Cardinal Health, Inc., which was founded in 1971. Intel Corporation's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Cardinal Health, Inc..

How many employees does Cardinal Health, Inc. have compared to Intel Corporation?

Cardinal Health, Inc. employs approximately 63,900 people, while Intel Corporation employs approximately 85,100. Intel Corporation has the larger workforce at 85,100 employees, compared to Cardinal Health, Inc.'s 63,900. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Cardinal Health, Inc. and Intel Corporation headquartered?

Both Cardinal Health, Inc. and Intel Corporation are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.

Who founded Cardinal Health, Inc. and Intel Corporation?

Cardinal Health, Inc. was founded by Robert D. Walter. Intel Corporation was founded by Robert Noyce, Gordon Moore.

Which company has a longer operating history — Cardinal Health, Inc. or Intel Corporation?

Intel Corporation has been operating for approximately 58 years, making it the more established of the two companies. Cardinal Health, Inc. has been in operation for around 55 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Cardinal Health vs Intel overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.